Results for tag: "Excessive Daytime Sleepiness Drug"

Excessive Daytime Sleepiness (EDS) is a condition characterized by an inability to stay awake during the day, even after getting adequate sleep at night. It is a common symptom of a variety of sleep disorders, such as narcolepsy, obstructive sleep apnea, and shift work disorder. Treatment for EDS typically involves the use of central nervous system (CNS) drugs, such as stimulants, wake-promoting agents, and antidepressants. Stimulants are the most commonly prescribed CNS drugs for EDS. These drugs work by increasing alertness and decreasing fatigue. Common stimulants used to treat EDS include methylphenidate, dextroamphetamine, and modafinil. Wake-promoting agents, such as armodafinil and sodium oxybate, are also used to treat EDS. These drugs work by increasing wakefulness and decreasing sleepiness. Antidepressants, such as bupropion and trazodone, are also used to treat EDS. These drugs work by increasing alertness and decreasing fatigue. There are a number of companies that produce CNS drugs for the treatment of EDS. These include pharmaceutical companies such as Pfizer, GlaxoSmithKline, and Merck, as well as generic drug manufacturers such as Teva Pharmaceuticals and Mylan. Show Less Read more